Sign In  |  Register  |  About Daly City  |  Contact Us

Daly City, CA
September 01, 2020 1:20pm
7-Day Forecast | Traffic

  • Search Hotels in Daly City

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Context Therapeutics

Recent news which mentions Context Therapeutics

Context Therapeutics CEO Marty Lehr notes progress towards the clinic with CTIM-76 in 2Q update
Tickers CNTX
Tags Context Therapeutics XNAS:CNTX
From TheNewswire.com - RSS (Media)
Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update
Tags XNAS:CNTX Context Therapeutics
From TheNewswire.com - RSS (Media)
ASCO 2023 – Claudin 6 Makes A Splash In Ovarian Cancer
Tickers AMGN BNTX CNTX
Tags CNTX Biotech AMGN
From Benzinga
Context Therapeutics CTIM-76 bispecific antibody preclinical data presented at AACR Annual Meeting
Tags Context Therapeutics XNAS:CNTX
From TheNewswire.com - RSS (Media)
Significant Unmet Need In Solid Tumors Reported, And How Context Therapeutics (NASDAQ: CNTX) Plans To Make A Difference
Tickers CNTX
Tags CNTX Benzinga Penny Stocks
From Benzinga
Lab Notes: Center for Breakthrough Medicines expands offerings; Researchers identify key 'gene signature'
Tickers INNO
Tags Andrew Kossenkov Avi Fischer Biotech
From Business Journals
Lab Notes: Baudax Bio completes $5M stock sale; Incyte licenses skin disease therapy
Tickers INNO
Tags Incyte Corp/ Health Care Endo International plc
From Business Journals
Context Therapeutics announces bispecific antibody clinical candidate to treat CLDN6+ cancers
Tags XNAS:CNTX Context Therapeutics
From TheNewswire.com - RSS (Media)
Context Therapeutics Partners With Integral Molecular To Develop An Emerging Cancer Drug
Tickers CNTX
Tags General Integral Molecular Market News
From Benzinga
New Ammo In The Battle Against Cancer – Context Therapeutics Sees Promising Results For Several Novel Drugs
Tickers CNTX
Tags General Market News Partner Content
From Benzinga
Lab Notes: Wistar Institute gets $5M NCI grant extension; Aclaris expands management team
Tickers INNO
Tags Aclaris Therapeutics Inc/ Trevena Inc/ Health Care
From Business Journals
Lab Notes: Oncora Medical doubles its client base; Context Therapeutics posts promising cancer drug data
Tickers INNO
Tags Inno Pharmaceuticals Ben Franklin Technology Partners
From Business Journals
What About Women? This Company Targets Female-Focused Cancers
Tickers CNTX
Tags Market News Partner Content Context Therapeutics
From Benzinga
Context Therapeutics raises $31M in fresh funding from stock sale
Tags Insurance Context Therapeutics Felix Kim
From Business Journals
Lab Notes: CHOP-based brain tumor network gets NIH boost; Integral Molecular inks deal with Astrazeneca
Tickers INNO
Tags Biotech Inno Pharmaceuticals
From Business Journals
Lab Notes: Trice gets FDA approval for device; Ocugen files to begin Covid-19 vaccine trial
Tickers INNO
Tags OptiNose Inc/ Health Care Ocugen Inc/
From Business Journals
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 DalyCity.com & California Media Partners, LLC. All rights reserved.